No Result
View All Result
China Secrets Revealed
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
No Result
View All Result
China Secrets Revealed
No Result
View All Result
Home News

Stopgap spending bill to avoid government shutdown expected to pass Congress despite right-wing opposition

by
January 16, 2024
in News
0
Stopgap spending bill to avoid government shutdown expected to pass Congress despite right-wing opposition
Read this article for free!
Plus get unlimited access to thousands of articles, videos and more with your free account!
Please enter a valid email address.
By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your email and follow the instructions provided.

Congress is expected to pass a short-term federal funding extension known as a continuing resolution (CR) this week aimed at avoiding a government shutdown.

It’s expected to pass with support from Republican and Democrat leaders who have agreed on little beyond the idea that shutting down the government is a bad idea both practically and politically.

The Republican majority in the House has experienced deep fractures over federal spending, with a growing bloc of conservatives declaring they prefer a government shutdown to an extension of the previous Democrat Congress’s spending priorities.

Within hours of the CR legislative text being made public, the hard-line right House Freedom Caucus panned it as a ‘surrender.’ Johnson, meanwhile, argued that the extra time will keep Republicans on track to secure conservative policy victories in the spending fight.

The ultra-conservative faction has had outsized influence on the House GOP majority for much of this Congress, particularly on bills that rely on Republican votes to pass. 

But two GOP aides who spoke with Fox News Digital anticipate that there’s little the Freedom Caucus and its allies can do about stopping the CR. 

It’s uncertain whether House GOP leaders will secure support from a majority of their own members, given the current political climate on spending, both aides suggested.

‘It’ll be a showdown for sure,’ one Republican aide told Fox News Digital. They said earlier, ‘The Freedom Caucus offers nothing more than criticism without a single suggestion to avert a government shutdown, and progressives want to spend more money than what this agreement represents.’

‘That leaves the typical coalition of Republicans and Democrats who will get this CR across the finish line,’ the aide predicted. ‘While this bill will pass on the House Floor, more Republicans than in the past will be forced to vote against this CR for political reasons.’

Meanwhile, a GOP aide to a moderate lawmaker blamed that political climate on the eight House Republicans led by Rep. Matt Gaetz, R-Fla., who ousted ex-Speaker Kevin McCarthy, R-Calif., in October.

‘Thanks to the Gaetz gang who were more concerned with getting political revenge on Kevin McCarthy with help from Democrats, the House will once again be forced to pass a CR rather than deliver the spending reform we promised,’ the second aide said.

The new CR would extend the two current government funding deadlines from Jan. 19 and Feb. 2 to March 1 and March 8.

This post appeared first on FOX NEWS
Previous Post

What’s next for Gov. DeSantis after second place finish in Iowa?

Next Post

Higher Education in Libertarian Land

Next Post
Higher Education in Libertarian Land

Higher Education in Libertarian Land

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Trump Attempts Price Controls on Prescription Drugs

Trump Attempts Price Controls on Prescription Drugs

0
TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

0
Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

0
In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

0
Trump Attempts Price Controls on Prescription Drugs

Trump Attempts Price Controls on Prescription Drugs

May 12, 2025
Trump says China agrees to ‘fully’ open country’s markets to US businesses

Trump says China agrees to ‘fully’ open country’s markets to US businesses

May 12, 2025
Trump defends Qatar jumbo jet offer as troubled Boeing fails to deliver new Air Force One fleet

Trump defends Qatar jumbo jet offer as troubled Boeing fails to deliver new Air Force One fleet

May 12, 2025
President Trump takes on ‘Big Pharma’ by signing executive order to lower drug prices

President Trump takes on ‘Big Pharma’ by signing executive order to lower drug prices

May 12, 2025

Recent News

Trump Attempts Price Controls on Prescription Drugs

Trump Attempts Price Controls on Prescription Drugs

May 12, 2025
Trump says China agrees to ‘fully’ open country’s markets to US businesses

Trump says China agrees to ‘fully’ open country’s markets to US businesses

May 12, 2025
Trump defends Qatar jumbo jet offer as troubled Boeing fails to deliver new Air Force One fleet

Trump defends Qatar jumbo jet offer as troubled Boeing fails to deliver new Air Force One fleet

May 12, 2025
President Trump takes on ‘Big Pharma’ by signing executive order to lower drug prices

President Trump takes on ‘Big Pharma’ by signing executive order to lower drug prices

May 12, 2025

Disclaimer: ChinaSecretsRevealed.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.

No Result
View All Result
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.